Compounds > 2-(n,n-dimethylamino)-6,7-dihydroxytetralin
Page last updated: 2024-09-03

2-(n,n-dimethylamino)-6,7-dihydroxytetralin and lead

2-(n,n-dimethylamino)-6,7-dihydroxytetralin has been researched along with lead in 1 studies

Compound Research Comparison

Studies
(2-(n,n-dimethylamino)-6,7-dihydroxytetralin)		Trials
(2-(n,n-dimethylamino)-6,7-dihydroxytetralin)		Recent Studies (post-2010)
(2-(n,n-dimethylamino)-6,7-dihydroxytetralin)		Studies
(lead)		Trials
(lead)		Recent Studies (post-2010) (lead)
460037,00221414,398

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lane, JD; Lasley, SM1

Other Studies

1 other study(ies) available for 2-(n,n-dimethylamino)-6,7-dihydroxytetralin and lead

ArticleYear
Diminished regulation of mesolimbic dopaminergic activity in rat after chronic inorganic lead exposure.
    Toxicology and applied pharmacology, 1988, Sep-30, Volume: 95, Issue:3

    Topics: 4-Butyrolactone; Animals; Dopamine; Dose-Response Relationship, Drug; Lead; Limbic System; Rats; Receptors, Dopamine; Tetrahydronaphthalenes

1988